Mefloquine inhibits cholinesterases at the mouse neuromuscular junction

Neuropharmacology

Volumn 49, Issue 8, 2005, Pages 1132-1139

  McArdle, Joseph J ^a,b   Sellin, Lawrence C ^a   Coakley, Kathleen M ^a   Potian, Joseph G ^a   Quinones Lopez, Mary C ^a   Rosenfeld, Clint A ^a   Sultatos, Lester G ^a   Hognason, Kormakur ^a  

^a The State University of New Jersey   (United States)

^b RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Acetylcholinesterase; Acetylcholinesterase knock out mouse; Asynchronous release; Butyrylcholinesterase

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; MEFLOQUINE; PHYSOSTIGMINE;

AMPLITUDE MODULATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVITY; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME INHIBITION; MINIATURE ENDPLATE POTENTIAL; MOUSE; NEUROMUSCULAR SYNAPSE; NONHUMAN; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL;

ACETYLCHOLINESTERASE; ANIMALS; ANTIMALARIALS; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; HUMANS; MEFLOQUINE; MEMBRANE POTENTIALS; MICE; MICE, KNOCKOUT; MOTOR ENDPLATE; NEUROMUSCULAR JUNCTION; PARASYMPATHETIC NERVOUS SYSTEM; PHYSOSTIGMINE; SYNAPSES;

EID: 27744464793     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2005.06.011     Document Type: Article

References (31)

1. M. Adler, H.A. Manley, A.L. Purcell, S.S. Deshpande, T.A. Hamilton, R.K. Kan, G. Oyler, O. Lockridge, E.G. Duysen, and R.E. Sheridan Reduced acetylcholine receptor density, morphological remodeling, and butyrylcholinesterase activity can sustain muscle function in acetylcholinesterase knockout mice Muscle Nerve 30 2004 317 327
2. S. Baudry, Y.T. Pham, B. Baune, S. Vidrequin, C. Crevoisier, F. Gimenez, and R. Farinotti Stereoselective passage of mefloquine through the blood-brain barrier in the rat J. Pharm. Pharmacol. 49 1997 1086 1090
3. C.J. Canfield, and R.S. Rozman Clinical testing of new antimalarial compounds Bull. World Health Organ. 50 1974 203 212
4. R. Duran, C. Cervenansky, and E. Karlsson Effect of fasciculin on hydrolysis of neutral and choline esters by butyrylcholinesterase, cobra venom and chicken acetylcholinesterases Toxicon 34 1996 959 963
5. S.J. Fuller, S. Naraqi, and G. Gilessi Paranoid psychosis related to mefloquine antimalarial prophylaxis P.N.G. Med. J. 45 2002 219 221
6. K. Hognason, K. Coakley, C. Rosenfeld, L.G. Sultatos, L.C. Sellin, and J.J. McArdle Mefloquine enhances spontaneous transmitter release and inhibits cholinesterase at the neuromuscular junction Soc. Neurosci. Abstr. 852.811 2004
7. S.S. Kelly The effects of age and nutritional state on m.e.p.p. amplitude Experientia 34 1978 200 201
8. H. Kollaritsch, J. Karbwang, G. Wiedermann, A. Mikolasek, K. Na-Bangchang, and W.H. Wernsdorfer Mefloquine concentration profiles during prophylactic dose regimens Wien. Klin. Wochenschr. 112 2000 441 447
9. B. Li, J.A. Stribley, A. Ticu, W. Xie, L.M. Schopfer, P. Hammond, S. Brimijoin, S.H. Hinrichs, and O. Lockridge Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse J. Neurochem. 75 2000 1320 1331
10. L.Y. Lim, and M.L. Go The anticholinesterase activity of mefloquine Clin. Exp. Pharmacol. Physiol. 12 1985 527 531
11. F.J. Lopez Antunano, and W.H. Wernsdorfer In vitro response of chloroquine-resistant Plasmodium falciparum to mefloquine Bull. World Health Organ. 57 1979 663 665
12. J.J. McArdle, and L.C. Sellin Mefloquine (Lariam) increases spontaneous transmitter release from mature and immature motor nerve terminals FASEB J. 17 2003 A634 (Abstr.)
13. J.J. McArdle, D. Angaut-Petit, A. Mallart, R. Bournaud, L. Faille, and J.L. Brigant Advantages of the Triangularis sterni muscle of the mouse for investigations of synaptic phenomena J. Neurosci. Methods 4 1981 109 115
14. McArdle, J.J., Sellin, L.C., Coakley, C.M., Potian, J.G., Hognason, K. Mefloquine selectively increases asynchronous acetylcholine release from motor nerve terminals, submitted for publication.
15. J. Minic, A. Chatonnet, E. Krejci, and J. Molgo Butyrylcholinesterase and acetylcholinesterase activity and quantal transmitter release at normal and acetylcholinesterase knockout mouse neuromuscular junctions Br. J. Pharmacol. 138 2003 177 187
16. J. Molgo, and S. Thesleff 4-Aminoquinoline-induced 'giant' miniature endplate potentials at mammalian neuromuscular junctions Proc. R. Soc. Lond. B Biol. Sci. 214 1982 229 244
17. C.J. Ohnmacht, A.R. Patel, and R.E. Lutz Antimalarials. 7. Bis(trifluoromethyl)-(2-piperidyl)-4-quinolinemethanols J. Med. Chem. 14 1971 926 928
18. W. Peters, J. Portus, and B.L. Robinson The chemotherapy of rodent malaria, XXVIII. The development of resistance to mefloquine (WR 142,490) Ann. Trop. Med. Parasitol. 71 1977 419 427
19. Y.T. Pham, F. Nosten, R. Farinotti, N.J. White, and F. Gimenez Cerebral uptake of mefloquine enantiomers in fatal cerebral malaria Int. J. Clin. Pharmacol. Ther. 37 1999 58 61
20. P.A. Phillips-Howard, and F.O. ter Kuile CNS adverse events associated with antimalarial agents. Fact or fiction? Drug Saf. 12 1995 370 383
21. E. Pous, J. Gascon, J. Obach, and M. Corachan Mefloquine-induced grand mal seizure during malaria chemoprophylaxis in a non-epileptic subject Trans. R. Soc. Trop. Med. Hyg. 89 1995 434
22. Z. Radic, R. Duran, D.C. Vellom, Y. Li, C. Cervenansky, and P. Taylor Site of fasciculin interaction with acetylcholinesterase J. Biol. Chem. 269 1994 11233 11239
23. M.M. van Riemsdijk, M.M. van der Klauw, J.A. van Heest, F.R. Reedeker, R.J. Ligthelm, R.M. Herings, and B.H. Stricker Neuro-psychiatric effects of antimalarials Eur. J. Clin. Pharmacol. 52 1997 1 6
24. C. Rosenfeld, A. Kousba, and L.G. Sultatos Interactions of rat brain acetylcholinesterase with the detergent Triton X-100 and the organophosphate paraoxon Toxicol. Sci. 63 2001 208 213
25. T.A. Ruff, S.J. Sherwen, and G.A. Donnan Seizure associated with mefloquine for malaria prophylaxis Med. J. Aust. 161 1994 453
26. L.H. Schmidt, R. Crosby, J. Rasco, and D. Vaughan Antimalarial activities of various 4-quinolonemethanols with special attention to WR-142,490 (mefloquine) Antimicrob. Agents Chemother. 13 1978 1011 1030
27. J.A. Simpson, R. Price, F. ter Kuile, P. Teja-Isavatharm, F. Nosten, T. Chongsuphajaisiddhi, S. Looareesuwan, L. Aarons, and N.J. White Population pharmacokinetics of mefloquine in patients with acute falciparum malaria Clin. Pharmacol. Ther. 66 1999 472 484
28. P. Taylor, and Z. Radic The cholinesterases: from genes to proteins Annu. Rev. Pharmacol. Toxicol. 34 1994 281 320
29. S. Thesleff, L.C. Sellin, and S. Tagerud Tetrahydroaminoacridine (tacrine) stimulates neurosecretion at mammalian motor endplates Br. J. Pharmacol. 100 1990 487 490
30. T. Weinke, M. Trautmann, T. Held, G. Weber, D. Eichenlaub, K. Fleischer, W. Kern, and H.D. Pohle Neuropsychiatric side effects after the use of mefloquine Am. J. Trop. Med. Hyg. 45 1991 86 91
31. E. Wooltorton Mefloquine: contraindicated in patients with mood, psychotic or seizure disorders Can. Med. Assoc. J. 167 2002 1147